Print PDF News

Irell Wins M&A Advisor Award for Representing Creditors Committee in Sale of Orexigen Therapeutics


Irell & Manella LLP’s representation of the official unsecured creditors’ committee in the 2018 sale of Orexigen Therapeutics, Inc. earned the firm the “Healthcare/Life Sciences Deal of the Year” award for deals under $500 million at The M&A Advisor’s Turnaround Awards. The deal team included Mitchell Cohen and Mike Strub. The honors are given annually to the leading transactions, firms and individuals in the distressed investing and reorganization industry.

Jump to Page